Citadel Advisors’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-25,593
| Closed | -$304K | – | 13265 |
|
|
2025
Q3 | $304K | Buy |
+25,593
| New | +$340K | ﹤0.01% | 10340 |
|
|
2024
Q2 | – | Sell |
-99
| Closed | -$10.3K | – | 14731 |
|
|
2024
Q1 | $29.7K | Buy |
99
+20
| +25% | +$5.97K | ﹤0.01% | 12705 |
|
|
2023
Q4 | $18.6K | Buy |
+79
| New | +$12.3K | ﹤0.01% | 12679 |
|
|
2023
Q3 | – | Sell |
-21
| Closed | -$3.59K | – | 14619 |
|
|
2023
Q2 | $3.59K | Buy |
+21
| New | +$3.52K | ﹤0.01% | 13680 |
|
|
2023
Q1 | – | Sell |
-503
| Closed | -$113K | – | 15027 |
|
|
2022
Q4 | $152K | Buy |
+503
| New | +$74.2K | ﹤0.01% | 10589 |
|
|
2022
Q3 | – | Sell |
-108
| Closed | -$6K | – | 13083 |
|
|
2022
Q2 | $6K | Sell |
108
-17
| -14% | -$1.26K | ﹤0.01% | 12662 |
|
|
2022
Q1 | $14K | Sell |
125
-838
| -87% | -$98.3K | ﹤0.01% | 13328 |
|
|
2021
Q4 | $138K | Buy |
963
+431
| +81% | +$78.2K | ﹤0.01% | 12374 |
|
|
2021
Q3 | $117K | Sell |
532
-536
| -50% | -$114K | ﹤0.01% | 12676 |
|
|
2021
Q2 | $247K | Buy |
1,068
+929
| +668% | +$236K | ﹤0.01% | 11719 |
|
|
2021
Q1 | $42K | Sell |
139
-1,222
| -90% | -$438K | ﹤0.01% | 12964 |
|
|
2020
Q4 | $512K | Buy |
1,361
+186
| +16% | +$65.2K | ﹤0.01% | 8096 |
|
|
2020
Q3 | $360K | Sell |
1,175
-1,437
| -55% | -$549K | ﹤0.01% | 7828 |
|
|
2020
Q2 | $982K | Buy |
2,612
+791
| +43% | +$224K | ﹤0.01% | 5862 |
|
|
2020
Q1 | $415K | Sell |
1,821
-874
| -32% | -$334K | ﹤0.01% | 6762 |
|
|
2019
Q4 | $1.43M | Sell |
2,695
-1,324
| -33% | -$717K | ﹤0.01% | 4964 |
|
|
2019
Q3 | $1.73M | Buy |
4,019
+239
| +6% | +$154K | ﹤0.01% | 4715 |
|
|
2019
Q2 | $4.5M | Sell |
3,780
-3,607
| -49% | -$4.31M | 0.01% | 3251 |
|
|
2019
Q1 | $9.2M | Sell |
7,387
-580
| -7% | -$664K | 0.01% | 2175 |
|
|
2018
Q4 | $7.54M | Sell |
7,967
-534
| -6% | -$643K | 0.01% | 2227 |
|
|
2018
Q3 | $12.2M | Sell |
8,501
-6,030
| -41% | -$9.12M | 0.01% | 1879 |
|
|
2018
Q2 | $23.4M | Buy |
14,531
+2,905
| +25% | +$5M | 0.03% | 1174 |
|
|
2018
Q1 | $18.9M | Buy |
11,626
+7,495
| +181% | +$15.6M | 0.03% | 1169 |
|
|
2017
Q4 | $6.94M | Buy |
4,131
+3,547
| +607% | +$4.69M | 0.01% | 2101 |
|
|
2017
Q3 | $817K | Buy |
584
+361
| +162% | +$424K | ﹤0.01% | 4599 |
|
|
2017
Q2 | $249K | Buy |
+223
| New | +$184K | ﹤0.01% | 6209 |
|
Other funds holding CBIO
BI
FFM
VA
FIS
VPC
OM
TCM
ACM
LGM